Literature DB >> 14507833

Distinct microtubule and chromatin characteristics of human oocytes after failed in-vivo and in-vitro meiotic maturation.

Catherine M H Combelles1, David F Albertini, Catherine Racowsky.   

Abstract

BACKGROUND: While a complete failure of meiotic maturation following hCG administration is rare during IVF cycles, cases arise in which patients repeatedly display a high incidence of failure to complete maturation to metaphase II (MII) in vivo. For the immature oocytes of such patients, our objectives were (i) to ask whether progression to MII could be supported in vitro, and (ii) to define their microtubule/chromatin properties following in-vitro maturation (IVM). Together, these studies were aimed at augmenting our understanding of factors underlying meiotic arrest in the human.
METHODS: Cases are presented here for two patients (A and B) producing oocytes that recurrently showed the inability to mature to metaphase II in vivo. Following IVM attempts, chromatin and microtubule characteristics were identified in those oocytes that remained arrested during meiosis I.
RESULTS: In patient A, meiotically arrested oocytes exhibited clear defects in spindle and chromatin arrangements. In contrast, the majority of oocytes from patient B displayed normal MI and MII spindles with aligned chromosomes, although some oocytes exhibited indications for possible defects in cell cycle control.
CONCLUSIONS: Together, these analyses illustrate two cases with oocytes exhibiting a common gross defect, that is meiotic maturation arrest, but revealing different aetiologies or manifestations as evidenced by the presence or absence of abnormal spindle/chromatin organization. This work reinforces the existence of intrinsic defects in oocytes of some patients, the molecular and cellular bases of which merit further investigation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14507833     DOI: 10.1093/humrep/deg419

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  8 in total

Review 1.  Acquisition of oocyte competence to develop as an embryo: integrated nuclear and cytoplasmic events.

Authors:  Marco Conti; Federica Franciosi
Journal:  Hum Reprod Update       Date:  2018-05-01       Impact factor: 15.610

Review 2.  Oocyte maturation failure: a syndrome of bad eggs.

Authors:  Stephanie Beall; Carol Brenner; James Segars
Journal:  Fertil Steril       Date:  2010-04-07       Impact factor: 7.329

3.  Bisphenol-A and human oocyte maturation in vitro.

Authors:  Ronit Machtinger; Catherine M H Combelles; Stacey A Missmer; Katharine F Correia; Paige Williams; Russ Hauser; Catherine Racowsky
Journal:  Hum Reprod       Date:  2013-07-30       Impact factor: 6.918

4.  Spontaneous in vitro maturation and artificial activation of human germinal vesicle oocytes recovered from stimulated cycles.

Authors:  Laura Escrich; Noelia Grau; Amparo Mercader; Carmen Rubio; Antonio Pellicer; María-José Escribá
Journal:  J Assist Reprod Genet       Date:  2010-10-22       Impact factor: 3.412

5.  COMPARISON OF MORPHOMETRIC AND MORPHOLOGY OOCYTES AFTER IN VITRO MATURATION BETWEEN HEALTHY WOMEN AND PATIENTS WITH POLYCYSTIC OVARIAN SYNDROME.

Authors:  A Allahveisi; E Yousefian; M J Rezaie; B Nikkhoo
Journal:  Acta Endocrinol (Buchar)       Date:  2019 Jul-Sep       Impact factor: 0.877

Review 6.  Large-scale chromatin morpho-functional changes during mammalian oocyte growth and differentiation.

Authors:  A M Luciano; V Lodde; F Franciosi; I Tessaro; D Corbani; S Modina
Journal:  Eur J Histochem       Date:  2012-08-10       Impact factor: 3.188

7.  Sirtuin Inhibition Adversely Affects Porcine Oocyte Meiosis.

Authors:  Liang Zhang; Rujun Ma; Jin Hu; Xiaolin Ding; Yinxue Xu
Journal:  PLoS One       Date:  2015-07-15       Impact factor: 3.240

8.  The variable success of in vitro maturation: can we do better?

Authors:  Alberto M Luciano; Federica Franciosi; Rodrigo G Barros; Cecilia Dieci; Valentina Lodde
Journal:  Anim Reprod       Date:  2018-08-03       Impact factor: 1.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.